Diagnosis & Disease Information

Vaccine

Personalized mRNA Vaccine Prolongs RFS in High-Risk Melanoma

By

Andrea S. Blevins Primeau, PhD, MBA

April 17, 2023

Adding an mRNA vaccine to adjuvant treatment with pembrolizumab prolongs relapse-free survival in high-risk melanoma, a phase 2 study suggests.

IV infusion

Chemotherapy Confers OS Benefit in HR+ Mucinous Breast Cancer

By

Jen Smith

April 17, 2023

Adjuvant chemotherapy provides a survival benefit for patients with hormone receptor-positive mucinous breast cancer, a retrospective study suggests.

Next post in AACR 2023

AACR 2023 Highlights Novel Research in NSCLC and ES-SCLC